Hence then, the article about arthex biotech announces first patient dosed in phase i iia arthemir trial for myotonic dystrophy type 1 dm1 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ARTHEx Biotech Announces First Patient Dosed in Phase I-IIa ArthemiR™ Trial for Myotonic Dystrophy Type 1 (DM1) )
Last updated :
Also on site :
- Americans are feeling inflation’s pinch into the holiday weekend. Here’s where prices are rising the most
- AI is changing the internet forever. Here’s how
- 1964 Beatles Cover Became a Hit That Paul McCartney Was ‘Honored By’ 62 Years Ago